REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 13th, 2002 • Idec Pharmaceuticals Corp / De • Biological products, (no disgnostic substances) • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of April 29, 2002 by and between IDEC Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated (the “Initial Purchaser”) pursuant to the Purchase Agreement, dated as of April 29, 2002 (the “Purchase Agreement”), between the Company and the Initial Purchaser. In order to induce the Initial Purchaser to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
ADDENDUM TO COLLABORATIVE DEVELOPMENT AGREEMENT SEIKAGAKU CORPORATION - IDEC PHARMACEUTICALS CORPORATIONCollaborative Development Agreement • May 13th, 2002 • Idec Pharmaceuticals Corp / De • Biological products, (no disgnostic substances)
THIS ADDENDUM TO COLLABORATIVE DEVELOPMENT AGREEMENT (“ADDENDUM”) is made and effective as of the 22nd day of March, 2002(“EFFECTIVE DATE”), by and between Seikagaku Corporation organized under Japanese law and having its principal executive offices at 1-5, Nihonbashi-honcho 2-chome, Chuo-ku, Tokyo 103-0023, Japan (“SK CORPORATION”) and IDEC Pharmaceuticals Corporation, a company (originally organized under the laws of the State of California and now organized under the laws of the State of Delaware) and having its principal executive offices at 3030 Callan Road, San Diego, California 92121, USA (“IDEC”), with reference to the following facts:
